Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $8.56 USD
Change Today -0.45 / -4.99%
Volume 852.2K
INFI On Other Exchanges
As of 5:20 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Julian Adams Ph.D.

President of Research & Development,Infinity Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 4 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Julian Adams, Ph.D., has been the President of Research & Development at Infinity Pharmaceuticals, Inc. since October 2007. Dr. Adams served the Senior Vice President of Research & Development at Infinity Pharmaceuticals Inc. since October 2003 and as its Chief Scientific Officer from September 2006 to May 2010. From December 1999 to October 2003, he served as a Senior Vice President of Drug Discovery & Development at Millennium Pharmaceuticals. He joined Millennium ...

Read Full Background

Corporate Headquarters*

780 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-453-1000
Fax: 617-453-1001

Board Members Memberships*



Massachusetts Institute of Technology
McGill University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$479,500

Stock Options*

All Other Compensation$2,879
Exercisable Options841,662
Exercisable Options Value$6,176,111
Unexercisable Options125,278
Unexercisable Options Value$453,995
Total Value of Options$6,630,105
Total Number of Options966,940

Total Compensation*

Total Annual Cash Compensation$722,129
Total Short Term Compensation$479,500
Other Long Term Compensation$2,879
Total Calculated Compensation$1,179,844
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $8.56 USD -0.45


James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Andrew Philip Witty Chief Executive Officer, Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline S.A.E
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at